Vietnam Bird Flu Vaccine Trial Gives Volunteers Second Shots
This article was originally published in PharmAsia News
Vietnam's clinical trial of its H5N1 vaccine took another step as the 30 military volunteers were given their second injections. The head of the Military Medical Academy, whose recruits are participating in the trial, said the institute's researchers would recommend using more academy volunteers for the next phase if the vaccine appears to be efficacious. Vietnam's National Institute of Hygiene and Epidemiology's Company for Vaccine and Biological Production No. 1, the drug's maker, expects to put the vaccine on the market next year at a cost of $1.88 per shot. (Click here for more
You may also be interested in...
Teligent has followed through with plans to condense its outstanding shares to raise their value and maintain a stock-exchange listing. Meanwhile, the company revealed a sizeable loss for the first quarter of this year, as it gave the latest on its warning letter-stricken facility in Buena, New Jersey.
Celltrion's Truxima has become the first rituximab biosimilar, and just the second biosimilar overall, to be prequalified by the World Health Organization.
Fresenius Kabi’s Idacio biosimilar adalimumab rival to Humira will from the start of June be marketed in Germany by Medac, following a deal between the two companies.